Sterne Agee Initiates Boston Scientific At Neutral

Sterne Agee initiated coverage on shares of Boston Scientific

with a Neutral rating. The target price for Boston Scientific is set to $13.50. Boston Scientific shares have surged 19.76% over the past 52 weeks, while the S&P 500 index has gained 17.38% in the same period. Boston Scientific's shares dropped 1.07% to close at $12.97 yesterday.